RecruitingNot ApplicableNCT03924791

Transforaminal Epidural Injection in Acute Sciatica

Sponsor

C.L.A.Vleggeert-Lankamp

Enrollment

142 participants

Start Date

Jun 1, 2019

Study Type

INTERVENTIONAL

Conditions

Sciatica Sciatica Due to Intervertebral Disc Disorder Sciatic Radiculopathy

Summary

Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms during this period of 'wait-and-see' is lacking. In this study, patients will be randomized to treatment with transforaminal epidural injections or standard oral pain medication.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone, a drug called Lidocaine, and others for people with sciatic radiculopathy, sciatica, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.